385 related articles for article (PubMed ID: 9119287)
1. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
Krulder JW; Strebus AF; Meinders AE; Briët E
Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
[TBL] [Abstract][Full Text] [Related]
2. The APTT response of pregnant plasma to unfractionated heparin.
Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.
Koestenberger M; Gallistl S; Muntean W; Leschnik B; Fritsch P; Cvirn G
Thromb Haemost; 2005 Jul; 94(1):69-74. PubMed ID: 16113786
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
Wang ZM; Li L; Li B; Guo SY
Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum.
Matsubara K; Matsuura Y; Bacic A; Liao M; Hori K; Miyazawa K
Int J Biol Macromol; 2001 Jun; 28(5):395-9. PubMed ID: 11325427
[TBL] [Abstract][Full Text] [Related]
7. The reduced anticoagulant effect of fondaparinux at low antithrombin levels.
Dempfle CE; Eichner J; Suvajac N; Ahmad-Nejad P; Neumaier M; Borggrefe M
Anesth Analg; 2009 Sep; 109(3):712-6. PubMed ID: 19690236
[TBL] [Abstract][Full Text] [Related]
8. Intersubject variability in the anticoagulant response to heparin in vitro.
Bjornsson TD; Wolfram KM
Eur J Clin Pharmacol; 1982; 21(6):491-7. PubMed ID: 6176454
[TBL] [Abstract][Full Text] [Related]
9. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
[TBL] [Abstract][Full Text] [Related]
10. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
[TBL] [Abstract][Full Text] [Related]
12. Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin.
Gouin-Thibault I; Samama MM
Thromb Haemost; 2009 May; 101(5):986-7. PubMed ID: 19404557
[No Abstract] [Full Text] [Related]
13. Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin.
Lehman CM; Rettmann JA; Wilson LW; Markewitz BA
Am J Clin Pathol; 2006 Sep; 126(3):416-21. PubMed ID: 16880140
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin concentrate in pediatric patients requiring unfractionated heparin anticoagulation: a retrospective cohort study.
Ryerson LM; Bauman ME; Kuhle S; Bruce AA; Massicotte MP
Pediatr Crit Care Med; 2014 Oct; 15(8):e340-6. PubMed ID: 24901804
[TBL] [Abstract][Full Text] [Related]
15. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
Brecher AS; Hellman K; Basista MH
Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
[TBL] [Abstract][Full Text] [Related]
16. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
Hellebrekers LJ; Slappendel RJ; van den Brom WE
Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
18. Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase.
Anderson JA; Fredenburgh JC; Stafford AR; Guo YS; Hirsh J; Ghazarossian V; Weitz JI
J Biol Chem; 2001 Mar; 276(13):9755-61. PubMed ID: 11134031
[TBL] [Abstract][Full Text] [Related]
19. Lack of in vitro interaction between heparin and nitroglycerin.
Barnes AD; Horn JR; Wittkowsky AK
Am J Clin Pathol; 1996 Mar; 105(3):298-300. PubMed ID: 8602610
[TBL] [Abstract][Full Text] [Related]
20. In vivo age dependency of unfractionated heparin in infants and children.
Newall F; Ignjatovic V; Summerhayes R; Gan A; Butt W; Johnston L; Monagle P
Thromb Res; 2009 Mar; 123(5):710-4. PubMed ID: 18829072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
